Ritsuko Kubota‐Koketsu

Ekaterinburg Research Institute of Viral Infections — Russia

Medicine · Health Sciences

17h-index983citations43works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(27), Respiratory viral infections research(17), Monoclonal and Polyclonal Antibodies Research(11), SARS-CoV-2 and COVID-19 Research(10), Immune Response and Inflammation(7)

Publications43 total

An Improved Dengue Virus Serotype-Specific Non-Structural Protein 1 Capture Immunochromatography Method with Reduced Sample Volume
Biosensors·2025Open Access
Dengue virus type 3 infection in a traveler returning from Costa Rica to Japan in 2023
Tropical Medicine and Health·2024· 1 citedOpen Access
Dengue virus type 3 infection in a traveler returning from Costa Rica to Japan in 2023
2024Open Access
Anti‐monkeypox virus‐neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan
Vox Sanguinis·2024
Changes in Anti–SARS-CoV-2 Antibody Titers of Pooled Plasma Derived From Donors in Japan: A Potential Tool for Mass-Immunity Evaluation
The Journal of Infectious Diseases·2023· 10 citedOpen Access
COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient
iScience·2023· 15 citedOpen Access
Decline in intravenous immunoglobulin titer against influenza virus A/H2N2 derived from donors in Japan
Journal of Medical Virology·2023Open Access
Live attenuated VZV vaccination induces antitumor immunity in ATLL patients
Cancer Immunology Immunotherapy·2022· 6 citedOpen Access
Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein
Scientific Reports·2022· 25 citedOpen Access
Preclinical study of a DNA vaccine targeting SARS-CoV-2
Current Research in Translational Medicine·2022· 24 citedOpen Access
<scp>HTLV</scp>‐1 Tax‐specific memory cytotoxic T lymphocytes in long‐term survivors of aggressive‐type adult T‐cell leukemia/lymphoma
Cancer Medicine·2022· 8 citedOpen Access
Antibody-Dependent Enhancement of IL-6 Production by SARS-CoV-2 Nucleocapsid Protein
Research Square (Research Square)·2022Open Access
Assessment of the potentially decreased neutralizing activities of intravenous immunoglobulin against future coronavirus variants
Transfusion·2021· 1 citedOpen Access
Infectivity assay for detection of SARS‐CoV‐2 in samples from patients with COVID‐19
Journal of Medical Virology·2021· 33 citedOpen Access
Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7
Biologics·2021· 5 citedOpen Access
Preclinical Study of DNA Vaccines Targeting SARS-CoV-2
SSRN Electronic Journal·2021Open Access
Neutralizing and binding activities against <scp>SARS‐CoV</scp>‐1/2, <scp>MERS‐CoV</scp>, and human coronaviruses <scp>229E</scp> and <scp>OC43</scp> by normal human intravenous immunoglobulin derived from healthy donors in Japan
Transfusion·2020· 22 cited
Comprehensive Analysis of Antibodies Induced by Vaccination with 4 Kinds of Avian Influenza H5N1 Pre-Pandemic Vaccines
International Journal of Molecular Sciences·2020· 2 citedOpen Access
Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma
Anticancer Research·2020· 12 citedOpen Access
Cytokine production in whole-blood cultures following immunization with an influenza vaccine
Human Vaccines & Immunotherapeutics·2018· 12 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Yoshinobu Okuno(21), Kazuyoshi Ikuta(17), Tatsuo Shioda(14), Tadahiro Sasaki(12), Mikihiro Yunoki(11), Emi E. Nakayama(8), Nobuko Ohshima(7), Yoshikazu Kurosawa(7), Yoshitaka Iba(6), Mayo Yasugi(5), Akifumi Yamashita(5), Takaaki Nakaya(5), Shoji Ideno(5), Y. Watanabe(5), Norihito Kawashita(4), Anariwa Du(4), Tadahiro Sasaki(4), Naphatsawan Boonsathorn(4), Yasuha Arai(4), Madiha S. Ibrahim(4)